glp 1 lilly direct ŌURA-LillyDirect collab highlights new GLP-1 care model Lilly releases Zepbound® (tirzepatide) single-dose
Description
A Spreading Patchwork of No CVS Caremark, the nations largest PBM, removed Zepbound from its standard formularies on July 1, 2025
And the differences go far beyond the number on the scale
(2024) 48:S32134
GLP-1 side effects are primarily gastrointestinal: nausea, vomiting, constipationusually mild and transient
203, no
